For years, health professionals have advised patients to limit their intake of saturated fat to reduce ...

For years, doctors followed the dietary guidelines of low fat, high carbohydrates for patients living with type 2 diabetes, but evidence now shows low carb delivers better results.
Low fat often fails to improve long-term glycaemic control or reduce medications.
Defeat Diabetes uses gold-standard evidence to guide patients to better blood glucose and remission through therapeutic carbohydrate reduction. La Trobe University's clinical study results evaluating the efficacy of our program will be released in 2025.
Backed by Diabetes Australia, the UK NHS, and the American Diabetes Association, low carb is the future of therapeutic diabetes management.
Type 2 diabetes is often seen as a progressive condition that will inevitably worsen over time. However, decades of randomised controlled trials have shown that it doesn't have to be—type 2 diabetes can be put into remission.

A 3-month study on obese Type 2 diabetes patients showed that severe carbohydrate restriction led to greater weight loss (-3.55 kg vs. -0.92 kg) and improved cholesterol:HDL ratio1. However, it increased relative saturated fat intake (13.9% vs. 11.0%).

The study found that a very low calorie ketogenic diet (VLCK) is safe and well-tolerated for short-term use in type 2 diabetes patients. It resulted in greater weight loss and improved glycemic control, with no serious adverse events reported.

The study compared a medium carb, low fat diet (MCCR) with a very low carb, high fat diet (LCK) in type 2 diabetes patients. The LCK group had greater HbA1c reductions, less medication use, and better glycemic control, while both groups lost weight

Participants in the very low carbohydrate ketogenic diet group saw significant improvements in glycemic control (HbA1c reduction) and weight loss compared to the control group1. They also experienced greater reductions in triglyceride levels and had a lower dropout rate.

The study compared a very low carb (VLC) diet with the DASH diet for adults with hypertension, prediabetes or type 2 diabetes, and overweight or obesity. The VLC diet led to greater improvements in systolic blood pressure, glycemic control, and weight over 4 months. Extra support did not significantly affect outcomes3.

A 6-month study comparing a 130g/day low carbohydrate diet (LCD) to a calorie-restricted diet (CRD) in patients with poorly controlled type 2 diabetes found that the LCD significantly reduced HbA1c and BMI more than the CRD, suggesting LCD as a beneficial nutrition therapy.

The study examined a low energy, low carbohydrate diet for type 2 diabetes patients. Over 12 weeks, participants on the diet lost an average of 9.5 kg and reduced HbA1c by 16.3 mmol/mol, compared to 2 kg weight loss and 0.7 mmol/mol HbA1c reduction in the control group.

The study compared three diets for type 2 diabetes management: a very low carb diet (6x6), a moderate low carb diet (LC), and an energy restricted diet (ER)1. The 6x6 diet led to greater weight loss, lower HbA1C levels, and reduced diabetes medication use over 12 months compared to LC and ER diets

In a one-year randomized trial, severely obese adults on a low carbohydrate diet lost an average of 5.1 kg, compared to 3.1 kg on a conventional diet. The low carb group saw greater improvements in triglyceride levels, HDL cholesterol, and hemoglobin A1c.

A non-calorie-restricted, low-carbohydrate diet significantly reduced HbA1c levels (from 7.6% to 7.0%) and triglyceride levels in Japanese patients with type 2 diabetes over six months, compared to a calorie-restricted diet, without major adverse effects.

Comparison of a low carb, ketogenic diet to a low glycemic index diet in 84 patients with type 2 diabetes over 24 weeks. The low carb diet resulted in better glycemic control and more frequent medication reductions/eliminations.

A study comparing a low carb diet (LCD) and a low fat diet with orlistat (LFD+O) in type 2 diabetes patients found that while both diets resulted in similar weight loss, the LCD significantly improved HbA1c levels and reduced the need for antiglycaemic medications more effectively than the LFD+O.

A low carb diet (LCD) significantly improves glycemic control and reduces body weight in type 2 diabetes patients compared to a low fat diet (LFD). The LCD group showed notable decreases in fasting blood glucose, HbA1c levels, and medication use, highlighting its potential for effective diabetes management.

A 6-week study found that a carbohydrate-reduced high-protein diet (CRHP) improved glycaemic control and reduced liver fat more effectively than a conventional diabetes diet (CD), despite similar weight loss in both groups. The CRHP diet also stabilized glucose levels and reduced fasting triacylglycerol.

The study found that a moderate low carb diet (90 g/day) significantly improved glycaemic control, reduced medication use, lowered blood pressure, and decreased weight, waist, and hip circumference in type 2 diabetes patients over 18 months, without adverse effects on lipid profiles, sdLDL, or carotid IMT1.

A 6-month low carb diet significantly improved glycaemic control, body composition, and did not negatively impact cardiovascular risk factors in type 2 diabetes patients1. Carbohydrate intake was reduced to 13.4%, fat intake increased to 63.2%, and notable reductions in HbA1c, weight, BMI, and waist circumference were observed.

The study found that a pharmacist-led, low carbohydrate, energy-restricted diet significantly reduced the need for glucose-lowering medications in type 2 diabetes patients1. Participants showed improvements in HbA1c, weight, blood pressure, and triglycerides, highlighting the potential of pharmacists in diabetes management.

The T2Diet Study found that a web-based low carb diet (LCD) program significantly improved glycaemic control in adults with type 2 diabetes. Over 16 weeks, participants saw notable reductions in HbA1c, weight, BMI, and anti-glycaemic medication requirements compared to standard care alone.

A 6-month randomized clinical trial found that a low carbohydrate diet significantly reduced HbA1c, fasting plasma glucose, and body weight in individuals with elevated HbA1c not on diabetes medication, suggesting potential benefits for preventing and treating type 2 diabetes, along with additional counselling and suppoprt.
Clinical evidence shows that low carb diets can lead to significant, lasting improvements in type 2 diabetes management. The programs here highlight the long-term benefits of a low carb lifestyle:

50% of participants achieved remission, with a 1.3% drop in HbA1c and 90% reducing or eliminating insulin use.

50% of patients achieved type 2 diabetes remission, significantly lowering their HbA1c and medication use over the years.

26% of participants reduced HbA1c below the diabetes threshold, and 40% cut back or stopped diabetes meds.

For years, health professionals have advised patients to limit their intake of saturated fat to reduce ...

Cardiovascular diseases, including heart attacks and strokes, are the leading causes of death worldwide, accounting for ...

Patient Profile: Name: KA Sex: Female Age: 60 Medical History: Type 2 Diabetes Mellitus (T2DM), Adjustable ...

A groundbreaking clinical study conducted by La Trobe University and published in Nature and npj Metabolic Health ...